95 related articles for article (PubMed ID: 8215486)
1. [Clinical significance of serum pepsinogen levels for prediction of recurrence in gastric carcinoma].
Maeda K; Chung YS; Onoda N; Nishimura S; Nitta A; Arimoto Y; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2079-81. PubMed ID: 8215486
[No Abstract] [Full Text] [Related]
2. [A case of a gastric cancer patient with high serum pepsinogen levels at relapse].
Kimura Y; Fujii T; Miyagawa N; Tanada S; Hamamoto K; Kimura S
Gan No Rinsho; 1990 Jul; 36(8):945-8. PubMed ID: 2366328
[TBL] [Abstract][Full Text] [Related]
3. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
[TBL] [Abstract][Full Text] [Related]
4. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
5. The relationship between gastric secretion and type of early gastric carcinoma.
Yoshihara M; Haruma K; Sumii K; Watanabe C; Kiyohira K; Kawaguchi H; Tanaka S; Kajiyama G
Hiroshima J Med Sci; 1995 Sep; 44(3):79-82. PubMed ID: 8567316
[TBL] [Abstract][Full Text] [Related]
6. [The variation and clinical significance of serum pepsinogen subgroups in atrophic gastritis and gastric cancer].
Jin HO; Zhang GZ; Kong XT
Zhonghua Nei Ke Za Zhi; 1986 Oct; 25(10):608-10, 637-8. PubMed ID: 3568844
[No Abstract] [Full Text] [Related]
7. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of serum pepsinogen I and II of patients with gastric cancer].
Kimura Y; Fujii T; Hamamoto K; Miyagawa N; Tsuda K; Tanada S; Iio A
Kaku Igaku; 1989 Sep; 26(9):1127-33. PubMed ID: 2810910
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen].
Tomooka Y
Nihon Koshu Eisei Zasshi; 1996 Feb; 43(2):118-25. PubMed ID: 8901216
[No Abstract] [Full Text] [Related]
12. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
[TBL] [Abstract][Full Text] [Related]
13. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma.
Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(6B):4489-93. PubMed ID: 11205293
[TBL] [Abstract][Full Text] [Related]
14. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical and immunologic analysis of pepsinogen I in blood serum and mucosa in patients with gastric tumors and non-tumor diseases].
Kalinovskiĭ VP; Belokhvostova AT; Shcherbakova AM; Bodrov IuF; Khanson KP
Vopr Onkol; 1998; 44(1):26-9. PubMed ID: 9578726
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
17. [Surgical management of locoregional recurrence of gastric carcinoma].
Hoksch B; Müller JM
Zentralbl Chir; 1999; 124(12):1087-90. PubMed ID: 10670093
[TBL] [Abstract][Full Text] [Related]
18. Prediction of lymph node metastasis by size of early gastric carcinoma.
Otsuji E; Kuriu Y; Ichikawa D; Ochiai T; Okamoto K; Yamagishi H
Hepatogastroenterology; 2007 Mar; 54(74):602-5. PubMed ID: 17523331
[TBL] [Abstract][Full Text] [Related]
19. [Peripheral plasma Big endothelin 1 levels in patients with gastric carcinoma undergoing radical gastrectomy and its relationship with tumor recurrence].
Teng XJ; Shen ZX; Xiang JJ; Shen L; Yuan L; Guo J; Wang XL
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):34-7. PubMed ID: 16437368
[TBL] [Abstract][Full Text] [Related]
20. [Mass screening of stomach neoplasms by serum pepsinogen analysis].
Miki K
Nihon Naika Gakkai Zasshi; 1992 May; 81(5):654-9. PubMed ID: 1512496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
